We selected 17 patients mean Age 51 years (range 33-87), Parity 2 ,5 (range 0-4), Menopause 10 patients (58,8%), Previous surgery procedure 17,6% (3-Hyst.), Post-menopausal pts were taking systemic or local estrogen therapy pts N= 17 Symptoms SUI grade l 11 pts(64,7%) gradell 5(29,4 %) grade lll 1(5,8 %) ingelman Sundberg score. Exclusion criteria: pacemaker or internal defibrillator or other implanted metallic or electronic device,permanent implant in the treated area,current or history of cancer or prelignant conditions, cardiac disorders, hormone replacement therapy,pregnancy or lactation, Impared immune response, History of current diseases stimulated by heat,diabetes active skin condition, in the treatment area, Skin disordes, Bleeding disorder, Any therapies or medications that may interfere with radiofrequency. Radiofrequency consists in the application of an electrical high frequency current ,ranging from 30KHz to 3000 KHz, The passage of electric current produces three physical phenomena that generates heat in the body tissues as a result of the resistance put up by those same tissues as the current passes through, low-temperature RF delivery results in thermal collagen denaturation elongated, crystalline collagen becomes random-coil gel, Collagen denaturation/healing phase occurs, results in reduced compliance of denatured tissue sites. lndications of radiofrequency: patients with type 1-2 sui,frail elderly population,after undergone multiple failed procedures,after radioterapy and\or radical hysterectomy,where the urethra is fixed and scarred,SUI after genito-urinary fistula surgery. Passive plate is applied in contact with the body in the sacral area without gel ,electrode active in different size with temperature sensor are applied in the external urethral meatus for 2 minutes and in the third middle urethra for 4 minutes,energy heats the connective tissue , shrink and stabilize endopelvic fascia and strengthen pubo-urethral ligaments, monouse covering used,automatic safety features monitor tissue temperatures and impedence is monitored on the display and temperature must always be in a range of 39-41 degrees.We use monopolar radiofrequency with 5 sessions once a week, don’t take anti -incontinence drugs , diuretics ,local or sistemic hormone therapy for menopause can be used, RF does not require anesthesia or antibiotic prophylaxis . Criteria to evaluate the result before and after Radiofrequency procedure, Standardized questionnaire, Urodynamic findings (VLPP), Subjective evaluation of leakage, 48 hours micturition diary, 24 hours pad-test, Cough test with a bladder filling of 300 ml